Tuberculosis

All Items

• 

  Identifying missing links – an ongoing outbreak of a novel tuberculosis strain in regional Queensland

  Bridget A O’Connor, Dr Arnold Bainomugisa, Dr Sushil Pandey, Ms Gemma L Devlin, Dr Christopher Coulter

• Tuberculosis workforce policy and development framework in Australia

  Ellen J Donnan, National Tuberculosis Advisory Committee

• A Five-year analysis of latent tuberculosis infection in Queensland, 2016–2020

  Marguerite Dalmau, Chris Coulter, Bridget O’Connor, Jennifer Robson, Emma Field, Stephen Lambert

• Australian recommendations for the management of drug-resistant tuberculosis, 2023

  Richard Stapledon, Ellen J Donnan, National Tuberculosis Advisory Committee (NTAC)

• The Use of whole genome sequencing for tuberculosis public health activities in Australia: a joint statement of the National Tuberculosis Advisory Committee and Communicable Diseases Genomics Network

  Ellen J Donnan, Ben J Marais, Chris Coulter, Justin Waring, ivan Bastian, Deborah A Williamson, Norelle L Sherry, Katherine Bond, Vitali Sintchenko, Ella M Meumann, Kristy Horan, Louise Cooley, Justin T Denholm

• Consensus statement on the use of a four-month treatment regimen for drug susceptible tuberculosis in children (< 10 years of age) with uncomplicated disease Endorsed by the Australian and New Zealand Paediatric Infectious Diseases (ANZPID) interest group of the Australasian Society of Infectious Diseases (ASID) and the National Tuberculosis Advisory Committee (NTAC) on behalf of the Communicable Diseases Network of Australia (CDNA)

  National Tuberculosis Advisory Committee

• Not everything that can be counted counts: defining and evaluating tuberculosis mortality in Australia

  Justin T Denholm, National Tuberculosis Advisory Committee

• The Strategic Plan for Control of Tuberculosis in Australia, 2021–2025

  National Tuberculosis Advisory Committee

• Revised guidelines for Australian laboratories performing mycobacteriology testing

  Ivan Bastian, Lisa Shephard, Richard Lumb, National Tuberculosis Advisory Committee

• Tuberculosis notifications in Australia, 2015–2018

  Amy Bright, Justin T Denholm, Chris Coulter, Justin Waring, Rick Stapledon, National Tuberculosis Advisory Committee

• Use of tuberculin skin test, chest radiograph and interferon-gamma release assay to select migrants for treatment of latent tuberculosis

  Michael G Flynn, Megan A Rees, Ayesha Saqib

  S2209-6051(18)00001-5

• Retrospective analysis of multidrug-resistant tuberculosis case notifications in Australia (1999–2018)

  Hendrik S. Camphor, Kerri Viney, Ben Polkinghorne, Kate Pennington

• The Strategic Plan for Control of Tuberculosis in Australia, 2016–2020: Towards Disease Elimination

  National Tuberculosis Advisory Committee

• Distribution of Bacillus Calmette–Guérin (BCG) Vaccine in Victoria 2013-2015

  NX Wong, N Crawford, J Lawrie, J Hickman, S Elia, J Buttery

  S2209-6051(18)00003-9

• Position statement on interferon-γ release assays for the detection of latent tuberculosis infection

  Ivan Bastian, Chris Coulter, National Tuberculosis Advisory Committee (NTAC)

  322-336

• How much does tuberculosis cost? An Australian healthcare perspective analysis

  EC Chan, A Nolan, JT Denholm

  191-194

• Tuberculosis notifications in Australia, 2014

  Cindy Toms, Richard Stapledon, Chris Coulter, Paul Douglas, National Tuberculosis Advisory Committee, Communicable Diseases Network Australia, Australian Mycobacterium Reference Laboratory Network

  243-259

• National position statement for the management of latent tuberculosis infection

  David Stock, National Tuberculosis Advisory Committee (NTAC)

  204-208

• National Tuberculosis Advisory Committee Guideline: Management of Tuberculosis Risk in Healthcare Workers in Australia

  Justin Waring, National Tuberculosis Advisory Committee

  119-203

• The Epidemiology of tuberculosis in the Australia Capital Territory, 2006-2015

  Belinda Jones, Vanessa Johnston, Ranil Appuhamy, Marlena Kaczmarek, Mark Hurwitz

  231-240

• Tuberculosis screening in an aged care residential facility in a low-incidence setting

  Nompilo Moyo, James Trauer, Peter Trevan, Ann-Marie Baker, Joseph Musemburi, Kerry McGrath, Aine Nolan, Eamon McIntyre, Jane Hulls, Justin T Denholm

  209-211

• Evaluation of bacille Calmette-Guérin immunisation programs in Australia

  Gulam Khandaker, Frank H Beard, Aditi Dey, Chris Coulter, Alexandra J Hendry, Kristine K Macartney

  33-48

• Multidrug-resistant tuberculosis in the Northern Territory: A 10-year retrospective case series

  Daniel Judge, Vicki L Krause

  334-339

• Defining a tuberculosis cluster or outbreak

  Justin Denholm, Chris Coulter, Ivan Bastian, National Tuberculosis Advisory Committee

  356-359

• Infection control guidelines for the management of patients with suspected or confirmed pulmonary tuberculosis in healthcare settings

  Chris Coulter, National Tuberculosis Advisory Committee (NTAC)

  360-366

• Treatment of latent tuberculosis in migrants to Victoria

  Michael G Flynn, Lynne K Brown

  578-583

• Policy recommendation: latent tuberculosis infection screening and treatment in children in immigration detention

  Vicki Krause, National Tuberculosis Advisory Committee

  597-598

• Supplemental use of an interferon-gamma release assay in a state-wide tuberculosis contact tracing program in Victoria: a six-year review

  Karen M Goebel, Ee L Tay, Justin T Denholm

  191-196

• Tuberculosis notifications in Australia, 2012 and 2013

  Cindy Toms, Richard Stapledon, Justin Waring, Paul Douglas, National Tuberculosis Advisory Committee, Communicable Diseases Network Australia, Australian Mycobacterium Reference Laboratory Network

  217-235

• Future reporting of tuberculosis in Australia

  Richard Lumb

  375

• Essential components of a tuberculosis control program within Australia

  National Tuberculosis Advisory Committee, Justin Waring

  397-400

• Tuberculosis in Australia: bacteriologically-confirmed cases and drug resistance, 2011 A report of the Australian Mycobacterium Reference Laboratory Network

  Richard Lumb, Ivan Bastian, Peter J Jelfs, Terillee J Keehner, Sushil K Pandey, Aina Sievers

  369-375

• Tuberculosis notifications in Australia, 2011

  Christina Bareja, Justin Waring, Richard Stapledon, Cindy Toms, Paul Douglas, National Tuberculosis Advisory Committee

  356-368

• Tuberculosis notifications in Australia, 2010

  Christina Bareja, Justin Waring, Richard Stapledon, National Tuberculosis Advisory Committee

  36-48

• National Tuberculosis Advisory Committee 2012 Committee Report

  Emily Gearside, National Tuberculosis Advisory Committee

  187-188

• The BCG vaccine: information and recommendations for use in Australia: National Tuberculosis Advisory Committee update October 2012

  No authors listed

  65-72

• Tuberculosis In Australia: Bacteriologically confirmed cases and drug resistance, 2010 A report of the Australian Mycobacterium Reference Laboratory Network

  Richard Lumb, Ivan Bastian, Robyn Carter, Peter Jelfs, Terillee Keehner, Aina Sievers

  40-46

• The Strategic plan for control of tuberculosis in Australia: 2011–2015

  National Tuberculosis Advisory Committee

  286-293

• Tuberculosis notifications in Australia, 2008 and 2009

  Christina Barry, Justin Waring, Richard Stapledon, Anastasios Konstantinos, National Tuberculosis Advisory Committee

  82-94

• Position statement on interferon-γ release assays in the detection of latent tuberculosis infection

  National Tuberculosis Advisory Committee

  125-131

• Feasibility of latent tuberculosis infection diagnosis by interferon-γ release assay remote from testing facilities

  James M Trauer, Krispin M Hajkowicz, Kevin G Freeman, Vicki L Krause

  168-171

• Tuberculosis in Australia: bacteriologically confirmed cases and drug resistance, 2008 and 2009

  Richard Lumb, Ivan Bastian, Robyn Carter, Peter Jelfs, Terillee Keehner, Aina Sievers

  154-161

• Zoonotic tuberculosis: on the decline

  Paul R Ingram, Peter Bremner, Tim J Inglis, Ronan J Murray, Debbie V Cousins

  339-341

• Tuberculosis in Australia: Bacteriologically confirmed cases and drug resistance, 2007

  Australian Mycobacterium Reference Laboratory Network, Richard Lumb, Ivan Bastian, Robyn Carter, Peter Jelfs, Terillee Keehner, Aina Sievers

  298-303

• Tuberculosis notifications in Australia, 2007

  Christina Barry, Anastasios Konstantinos

  304-315

• Epidemiology of laboratory confirmed tuberculosis in Victoria, 1990 to 2004

  Michelle E McPherson, David Leslie, Aina Sievers, Mahomed Patel, Heath Kelly

  237-241

• Tuberculosis notifications in Australia, 2006

  Paul W Roche, Vicki Krause, Anastasios Konstantinos, Ivan Bastian, Ral Antic, Lynne Brown, Amanda Christiansen, Sandra Gebbie, Mark Hurwitz, Avner Misrachi, Justin Waring, National Tuberculosis Advisory Committee

  1-11

• Tuberculosis in Australia: bacteriologically confirmed cases and drug resistance, 2006: A report of the Australian Mycobacterium Reference Laboratory Network

  Richard Lumb, Ivan Bastian, Chris Gilpin, Peter Jelfs, Terillee Keehner, Aina Sievers, Australian Mycobacterium Reference Laboratory Network

  12-17

• Position statement on interferon-γ release immunoassays in the detection of latent tuberculosis infection, October 2007

  National Tuberculosis Advisory Committee

  404-405

• National Tuberculosis Advisory Committee multi-drug resistant tuberculosis: Information Paper (October 2007)

  National Tuberculosis Advisory Committee

  406-409

• Tuberculosis notifications in Australia, 2005

  Paul Roche, Ivan Bastian, Vicki Krause, Ral Antic, Lynne Brown, Amanda Christiansen, Christina Drummond, Sandra Gebbie, Mark Hurwitz, Anastasios Konstantinos, Avner Misrachi, National Tuberculosis Advisory Committee

  71-80

• Tuberculosis in Australia: bacteriologically confirmed cases and drug resistance, 2005 A Report of the Australian Mycobacterium Reference Laboratory Network

  Richard Lumb, Ivan Bastian, Chris Gilpin, Peter Jelfs, Terillee Keehner, Aina Sievers, Australian Mycobacterium Reference Laboratory Network

  80-86

• Tuberculosis notifications in Australia, 2004

  Paul Roche, National Tuberculosis Advisory Committee

  93-101

• Tuberculosis in Australia: bacteriologically confirmed cases and drug resistance, 2004 A Report of the Australian Mycobacterium Reference Laboratory Network

  Richard Lumb, Ivan Bastian, Taryn Crighton, Chris Gilpin, Frank C Haverkort, Aina S Sievers

  102-108

• The BCG vaccine: information and recommendations for use in Australia

  National Tuberculosis Advisory Committee

  109-115

• Guidelines for Australian Mycobacteriology Laboratories

  National Tuberculosis Advisory Committee

  116-128

• Tuberculosis notifications in Australia, 2003

  Janet Li, Paul Roche, Jenean Spencer, Ivan Bastian, Amanda Christensen, Mark Hurwitz, Anastasios Konstantinos, Vicki Krause, Moira McKinnon, Avner Misrachi, Graham Tallis, Justin Waring, National Tuberculosis Advisory Committee

  464-473

• Tuberculosis in Australia: bacteriologically confirmed cases and drug resistance, 2003. A report of the Australian Mycobacterium Reference Laboratory Network

  Richard Lumb, Ivan Bastian, Taryn Crighton, Chris Gilpin, Frank Haverkort, Aina Sievers

  474-480

• Tuberculosis in Australia: bacteriologically confirmed cases and drug resistance, 2002: A report of the Australian Mycobacterium Reference Laboratory Network

  Richard Lumb, Ivan Bastian, WilliamD Chew, Chris Gilpin, Frank Haverkort, Aina Sievers

  459-465

• Tuberculosis notifications in Australia, 2002

  Gina Samaan, Paul Roche, Jenean Spencer, National Tuberculosis Advisory Committee Krause

  448-457